A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with moderate or severe hepatic impairment.
Epistemonikos ID: e1d73f4627d022b6f54e29aef9234083888d9b6f
First added on: May 01, 2026